Brought to you by 
Optimer licenses clinical-stage vaccine from Sloan-Kettering
22 Feb 2016
Executive Summary
Optimer Pharmaceuticals (drug discovery based on carbohydrate science) licensed exclusive worldwide rights to a clinical development-stage globo H vaccine from Memorial Sloan-Kettering Cancer Center.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com